MAY 22·Stock TitanLow
ClearPoint Neuro (CLPT) director converts 12,417 RSUs into common shares
ClearPoint Neuro director Timothy T. Richards converted 12,417 restricted stock units (RSUs) into common shares, increasing his direct ownership to 92,613 shares. This transaction was a scheduled vesting of previously granted equity, not an open-market purchase or sale. The RSUs were granted on May 22, 2025, and vested at no cash exercise price.